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Förster resonance energy transfer (FRET) is a quantum effect of energy 
transfer from the donor chromophore to the acceptor one via non-radiative dipole-
dipole coupling when those chromophores are positioned close enough and in the 
right orientation to each other. Genetically encoded FRET sensors consist of 
donor and acceptor fluorescent protein pair (usually CFP/YFP) and a protein 
based sensing domain in between which responds to the presence or the activity 
of desired molecule via conformational change resulting in change of FRET 
efficiency. In this thesis, I developed a genetically encoded FRET sensor for 
detecting double stranded RNA (dsRNA) during viral infection. The response of 
eukaryotic cells to infection by RNA viruses is based to a large extent on the 
regulation by protein kinase R. Protein kinase R (PKR, RNA-regulated protein 
kinase, eIF2α kinase 2) becomes activated via homodimerisation in the presence 
of double-stranded RNA produced during replication of RNA viruses (or if 
endogenously present). Active PKR phosphorylates its target – mostly α subunit 
of eIF2 – and inhibits the translation of viral proteins. PKR is a two domain 
protein which consists of an N-terminal double-stranded RNA binding 
domain (RBD) and a C-terminal catalytic domain separated by a 100-amino acid 
unstructured region. The idea exploited in the current project is based on the 
ability of the N-terminal PKR domain to undergo a conformational change when 
binding double-stranded RNA, hence functioning as a sensor for double-stranded 
RNA. The fluorescent sensor is completed by the addition of the fluorescent 
proteins mTurquoise and cp173Venus forming a FRET pair. I successfully tested 
the sensor termed KPR1 in vitro as well as in HeLa Kyoto cells against double-
stranded RNA and found a high FRET increase upon binding. The sensor 
responded well to the presence of self-replicating subgenomic Hepatitis C Virus 
RNA replicon in Huh7 cells. The data on detection of full Hepatitis C infection 




Förster-Resonanzenergietransfer (FRET) ist ein quantenmechanischer 
Effekt des Energietransfers von einem Donor-Chromophor auf einen Akzeptor-
Chromophor durch strahlungslose Dipol-Dipol Kopplung, wenn diese 
Chromophore nahe genug beieinander liegen und die richtige Orientierung haben. 
Genetisch kodierte FRET Sensoren bestehen aus einem Paar fluoreszierender 
Proteinen, dem Donor und Akzeptor (üblicherweise CFP/YFP) und einer 
dazwischenliegenden Protein-basierten Sensordomäne, die auf die Anwesenheit 
oder die Aktivität eines Moleküls durch Konformationsänderung reagiert, die in 
einer Änderung der FRET Effizienz resultiert.  
In dieser Dissertation entwickelte ich einen genetisch kodierten FRET 
Sensor für die Detektion doppelsträngiger RNA (dsRNA) während viraler 
Infektion. Die Antwort eukaryontischer Zellen auf die Infektion durch RNA-
Viren basiert hauptsächlich auf der Regulation der Proteinkinase R. Proteinkinase 
R (PKR, RNA-regulierte Proteinkinase, eIF2α kinase 2) wird durch 
Homodimerisierung aktiviert in der Anwesenheit doppelsträngiger RNA, die 
während der Replikation von RNA-Viren erzeugt wird (oder falls endogen 
vorhanden). Die aktivierte PKR phosphoryliert das Zielprotein – meist handelt es 
sich dabei um die α-Untereinheit von eIF2 – und inhibiert the Translation viraler 
Proteine. PKR ist aus zwei Domänen aufgebaut, die aus einer N-terminalen 
doppelsträngigen RNA Bindedomäne (RBD) und einer C-terminalen 
katalytischen Domäne bestehen, getrennt durch eine unstrukturierte Region mit 
der Länge von 100 Aminosäuren. Das gegenwärtige Projekt basiert auf der 
Fähigkeit der N-terminalen PKR-Domäne, konformationelle Umlagerungen bei 
Bindung doppelsträngiger RNA zu untergehen und so als Sensor für 
doppelsträngige RNA zu fungieren. Der fluoreszierende Sensor wird 
vervollständigt durch die fluoreszierenden Proteine mTurquoise und 
cp173Venus, die ein FRET-Paar bilden. Erfolgreich testete ich den Sensor KPR1 
in vitro und in HeLa Kyoto Zellen in Anwesenheit doppelsträngiger RNA und 
fand einen deutlichen FRET-Anstieg infolge der Bindung. Der Sensor zeigte eine 
gute Antwort auf die Anwesenheit des selbst-replizierenden subgenomischen 
Hepatitis C Virus RNA Replicons in Huh7 Zellen. Die Daten für die Detektion 




Motivation and scientific background 
Studying the biology of viral infection and virus-host interactions has been 
an important research area for a long time. Understanding the impact of viral 
infection on the cell and collecting comprehensive data about every stage of 
infection (cell entry, replication and the release of newly formed viral particles) 
is key for developing a cure from the pathogens. 
Viruses are commonly classified according to the type of their genetic 
material and their method of replication (Baltimore classification) (Matthews and 
Maurin, 1979, King et al., 2018): 
1) double-stranded DNA viruses (Adenoviruses, Herpesviruses); 
2) positive sense single-stranded DNA viruses (Parvoviruses); 
3) double-stranded RNA viruses (Reoviruses); 
4) positive sense single-stranded RNA viruses (Picornaviruses, Togaviruses, 
Flaviviridae, Hepatitis C Virus (HCV), Dengue virus (DENV)); 
5) negative sense single-stranded RNA viruses (Orthomyxoviruses, 
Rhabdoviruses); 
6) single-stranded RNA-RT viruses (Retroviruses); 
7) double-stranded DNA-RT viruses (Hepadnaviridae). 
The tools currently used to investigate viral infection (many of which are 
also incompatible with live cell research) exhausted themselves in terms of the 
information which can be collected. There is a growing request for new tools 
which can provide information with precise temporal and spatial resolution and 
based on observation and manipulation of intact live cells. In this work I aimed 
to contribute to the pool of newly emerging tools helping the virologists to 
understand pathogen-host interactions better. My interest was among RNA 
viruses (with the example of Hepatitis C Virus (HCV) which is arguably the best 
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studied RNA viruses). I decided to focus on the replication stage of the virus and 
produce a tool which is compatible with live cell research. 
RNA-viruses 
As was previously mentioned, viruses can be classified according to the 
type and polarity of nucleic acid molecules in the viral particle. RNA viruses 
include positive-sense single-stranded RNA viruses (class IV), negative-sense 
single-stranded RNA viruses (class V, also included ambisense RNA viruses), 
double-stranded RNA viruses (class III) and retroviruses (class VI). Viral particle 
usually contains from one to dozen copies of the nucleic acid genome together 
with viral proteins like polymerase or protease to help viral replication inside the 
cell. In the following paragraph I will mostly focus on the replication features of 
RNA viruses.  
Positive-sense single-stranded RNA viruses form the largest group of RNA 
viruses. These viruses contain a single-stranded RNA molecule as a genome 
which is similar to cellular mRNA and thereby can be translated by the host cell 
machinery (Koonin and Dolja, 1993) Virion often contains viral RNA-dependent 
RNA polymerase enzymes (RNA replicase) to produce a negative strand which 
will be used as a template for the production of new positive-sense single-
stranded RNAs destined to be packaged into the new viral particle (although the 
presence of the replicase in a viral particle is not necessary, it can be produced 
from a viral positive-sense RNA) (Figure 1a). Viral RNA positive strand is 
translated into a single protein polypeptide which later is processed by viral 
proteases and sometimes host enzymes to form several vital viral 
proteins (polymerase, protease, various structure proteins). RNA of positive-
sense viruses can be infectious by itself even without the presence of a full viral 
particle since it encodes all the necessary proteins for the formation of a new 
virion.  The infection power is obviously less than of a full virus but this ability 
of a positive-sense viral RNA is used in research to study viruses. All viral RNA 
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molecules have a conserved region which is called internal ribosome entry 
side (IRES) in their 5’-UTR (untranslated) region. It is a complicated three- or 
four-way secondary structure containing many RNA loops and used for host 
ribosome recognition and initiation of translation. The replication of these type 
of viruses involves the presence of double-stranded RNA intermediates of 
negative-sense RNA templates and a positive-sense future viral RNAs. The ratio 
of positive-sense RNAs to negative sense RNAs is understandably steered 
towards positive-sense ones (for instance, 10 times for Hepatitis C Virus). 
Negative-sense viral RNA is complementary to mRNA and thus must be 
converted to positive-sense RNA by an RNA-dependent RNA polymerase (RNA 
replicase) before translation (Li et al., 2015) (Figure 1b). Other than that, this type 
of viruses is similar to the positive-sense single-stranded RNA viruses in many 
ways. One of the differences is that purified RNA of a negative-sense virus is not 
infectious by itself as it needs to be transcribed into positive-sense RNA. It is also 
for the same reason essential that a viral particle contains replicase enzyme inside 
a virion. There are reports that the amount of double-stranded RNA intermediate 
during the replication of a virus can be much lower than that of positive-sense 
RNA viruses (Weber et al., 2006).  
An interesting type of single-stranded RNA viruses are ambisense RNA 
viruses (Nguyen and Haenni, 2003). They resemble negative-sense RNA viruses, 
except they also translate genes from the positive strand. Bunyaviruses have 
3 single-stranded RNA fragments containing both positive-sense and negative-
sense sections; arenaviruses are also single-stranded RNA viruses with an 
ambisense genome, as they have 2 fragments that are mainly negative-sense 
except for part of the 5'-ends of the large and small segments of their genome. 
The double-stranded viruses represent a diverse group of viruses that vary 
widely in host range (humans, animals, plants, fungi, and bacteria), genome 
segment number (one to twelve), and virion organization (Wickner, 1993, 
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Targett-Adams et al., 2008). Partly because of that, their viral particle 
organization and RNA can vary significantly. The 5'-part of double-stranded 
RNA genome may be naked, capped or covalently linked to a viral protein. Upon 
infection, the genomic double-stranded RNA is transcribed in mRNAs that will 
both serve for translation and/or replication. mRNAs translation produces the 
proteins necessary for viral proliferation. Replication occurs in the host cytoplasm 
and converts mRNA to double-stranded genomic RNA. The double-stranded 
RNA is a kind of molecule that cells do not produce, and eukaryotes have various 
antiviral systems that detect and inactivate double-stranded RNA. To circumvent 
this defenses, many double-stranded RNA viruses are replicating their RNA 
inside the capsids (Figure 1c). 
Retroviruses (Group VI) have a single-stranded RNA genome but, 
according to ICTV (International Committee on Taxonomy of Viruses), are not 
considered RNA viruses because they use DNA intermediates to replicate 
(Telesnitsky, 2010). Following the cell entry of a viral particle, the conversion of 
viral RNA genome in the cytoplasm begins. First, a complementary DNA strand 
is produced on top of the single-stranded viral RNA through the virion RNA-
dependent DNA-polymerase (reverse transcriptase). After that, reverse 
transcriptase builds another DNA strand on top of the newly produced while 
getting rid of the old RNA template. This double-stranded DNA intermediate 
forms a so-called preintegration complex (PIC) with viral and some of the host 
proteins. PIC enters the nucleus (with a still unclear mechanism) where viral 
integrase inserts viral cDNA into the genome. Transcription and translation of 
viral DNA follows, producing single polypeptide which is digested by viral 
protease into proteins required for retrovirus proliferation. The most famous 




Figure 1. Replication of different RNA viruses (adapted from © Pearson 
Education, Inc) 
Common for all RNA viruses is the fact that they have a much higher 
mutation rate compared to DNA viruses. Viral RNA polymerases are often 
inaccurate and lack proof-reading mechanisms like DNA polymerases 
have (especially reverse transcriptase of retroviruses). This is one reason why it 
is difficult to make effective vaccines to prevent diseases caused by RNA viruses. 
Another distinct feature of RNA viruses is that they produce double-stranded 
RNA intermediate during replication which has a very well-characterized cellular 
response represented mostly by the protein kinase R mediated pathway.   
Hepatitis C Virus 
I aimed to focus on HCV, an RNA virus. Hepatitis C Virus is a major 
causative agent of acute and chronic liver diseases in the world with an estimated 
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71 million affected patients worldwide (Luxenburger et al., 2018). 
Hepatitis C Virus is an enveloped, positive-sense single-stranded RNA virus. 
There are excellent reviews about the clinical relevance of Hepatitis C Virus 
(Modi and Liang, 2008), about treatment and therapies (Kaufmann et al., 2018, 
Kohli et al., 2014), immunological (Irshad et al., 2008), epidemiological (Memon 
and Memon, 2002), or inhibitor studies (Chen and Njoroge, 2009) 
I will focus mostly on the replication-relevant part of HCV biology. 
Hepatitis C Virus is a positive-sense single-stranded RNA virus. The genome is 
~9600 nucleotides which encodes a polypeptide proteolytically processed into 
distinct viral proteins (Figure 2). Translation begins via a ~340 nt long 5’-UTR 
region where IRES is located. The translated polypeptide is cut by viral protease 
into 9 distinct proteins.  
The first cleavage product is a core protein (c) forming the majority of 
nucleocapsid. Next are two envelope proteins E1 and E2. These are highly 
glycosylated type I transmembrane proteins which are forming 2 types of 
heterodimeric complexes: disulfide linked or non-covalently linked. E2 protein 
also was shown to bind cellular protein kinase R and inhibit it. Protein p7 is a 
highly hydrophobic polypeptide of unknown function.  
The remaining HCV genome encodes non-structural (NS) proteins named 
from 2 to 5. Most of these NS proteins are required for the replication of the virus. 
NS2 and the N-terminal part of NS3 translate into the NS2/3 protease which 
catalyzes cleavage at NS2/3 site. NS3 carries protease activities (cleavage of 
NS3/4A, SN4A/B, NS4B/5A, NS5A/B) and NTPase/helicase activity necessary 
for replication. NS4A is a cofactor of NS3 and is important for proteolytic activity 
of NS3, NS4B function is currently unclear. NS5A is a much phosphorylated 
protein and has a regulatory role in the replication of HCV and also involved in 
resistance to anti-viral interferons. NS5B is a RNA-dependent 
RNA-polymerase (Bartenschlager and Lohmann, 2000). 
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Liver is the main site of HCV replication. Virus attachment to the host cell 
during the infection involves the CD81 host receptor and the E2 HCV protein. 
Once inside the cytoplasm, HCV RNA is immediately translated. After the 
polypeptide has been synthesized and processed into essential viral proteins, a 
negative-sense strand is produced on top of the HCV genome to serve as a 
template for replication of new RNA. The amount of positive-sense RNA inside 
a cell can be estimated to be up to 50000 per cell, and the negative-sense RNA 
template around 10 times less. Viral RNA is transferred to the ER where the 
budding of new virions begins.  
Since HCV activity is mostly found in the liver, different types of 
hepatocyte cell lines (primary and immortalized) has been tried for Hepatitis C 
research. All efficient infectious HCV cell culture systems employ the human 
hepatoma cell line Huh7 or cell lines derived from Huh7, such as the Huh7.5 cell 
line, which are typically cultured in monolayers in cell culture flasks (Seipp et 
al., 1997, Sainz et al., 2009). Moreover, only a single HCV genotype isolate 
2a (JFH1) can recapitulate the complete viral life cycle in cell culture.  
The common way of studying Hepatitis C is to use RNA clones from the 
HCV genome (Lohmann et al., 1999). HCV is a positive-sense virus, meaning 
isolated viral RNA is infectious and can be used in appropriate cell lines. The 
infectivity of genome or subgenome clones is lower but usage of RNA instead 
of the full virus can be very convenient. The more widespread approach is to 
use not a full HCV clone, but rather subgenomic replicons coding proteins from 
NS2-NS5B or NS3-NS5B. The advantage is the lack of structural protein genes 
which makes formation of a new viral particle impossible and hence the 
experiment is more safe and easy to perform. These subgenomic replicons are 
perfect to study the replication stage of the virus, often by introducing a 




Figure 2. Schematic representation of the HCV genome (~9.6 kb, ~5kb structural 
genes, ~4.6 kb – replication genes). Adopted from (Bartenschlager and Lohmann, 
2000). 
For the same safety, simplicity and convenience reasons artificial HCV 
particles can be use. So-called trans-complementary particles (TCPs) are 
produced by introducing subgenomic replicon mentioned above into the Huh7 
cell line which stably expresses HCV structural proteins. The newly formed 
TCPs has all the properties of the full HCV, but the genome RNA consists only 
of replication proteins (from NS2 to SN5B) and is therefore unable to produce 
new particles after infecting the host cells. The advantage of TCPs over isolated 
subgenomic RNA replicons is better infectivity (more efficient way of 
introduction of the replicating RNA into the cell). 
Cellular response to the infection of RNA viruses 
Cellular response to a viral infection can affect many different aspects of 
the cell and trigger a very complicated cascade of reaction. In case of RNA 
viruses secreted Interferon I (INF1) induces responses which involve 
NFκB-mediated activation of transcription of stress proteins, induction of 
apoptotic proteins (mostly proteases) and, most importantly, inhibition of 




Figure 3. PKR: induction, activation and its role in different cellular pathways. 
Adopted from (Garcia et al., 2007) 
The most well-known, robust and studied path – inhibition of translation, 
is activated via the presence of double-stranded RNA inside the cell. Double-
stranded RNA is a replication intermediate for all RNA viruses (Appleby et al., 
2015). Presence of double-stranded RNA triggers protein kinase R (PKR, 
EIF2AK2)-mediated stress response. PKR is a part of the family of four stress 
kinases (HRI or EIF2AK1, PKR or EIF2AK2, PERK or EIF2AK3 and GCN2 or 
EIF2AK4) which are involved in cellular stress-response (de Haro et al., 1996). 
HRI kinase is activated during iron deficiency (Burwick and Aktas, 2017), PERK 
is involved during  protein misfolding and ER stress (Liu et al., 2015), GCN2 is 
related to amino acid starvation (Castilho et al., 2014), while PKR is known for 
its anti-viral activity. 
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PKR is present in the cytoplasm in low quantities in the latent state. RNA 
infection causes interferon to induce PKR production inside the cell. The kinase 
on by itself is not biologically active. During the infection, PKR can bind 
specifically and sequence-independently double-stranded RNA intermediate. 
Two molecules bind on top of double-stranded RNA which causes dimerization 
of two PKR monomers and subsequently trans-autophosphorylation in multiple 
serine and threonine sites. The activated kinase can later phosphorylate its 
downstream target, eIF2α subunit of eukaryotic initiation factor 2 (eIF2α), which, 
in turn, causes stalling of translation (initiation of translation to be precise). 
Phosphorylation of eIF2α prevents GDP dissociation from eIF2 in the ternary 
complex eIF2B/eIF2/GDP and inhibits the recycling of GTP/GDP prior to 
assembly of the 43S initiation complex (Figure 4). 
 
Figure 4. Model of PKR activation pathway. Adapted from (Dey et al., 2005) 
Translation halt if not reversed leads to cellular death via apoptosis. This 
state is often associated with the formation of the so-called stress-granules, which 
are complexes (or rather aggregates) of untranslated both viral and produced 
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mRNAs together with several of cellular and viral proteins. (Ruggieri et al., 2012, 
Roth et al., 2017). Stress-granules formation and oscillation are a great indicator 
of the state of viral infection. 
Evading anti-viral host response by RNA viruses is to large extend relying 
on blockading PKR by masking it with the viral proteins or causing its 
degradation inside the cell. (Dzananovic et al., 2018) 
I am going to focus more closely on two most noticeable and well-studied 
members of the anti-viral response to the infection: PKR and eIF2α, which can 
be promising targets for the development of a sensor. 
PKR structure and biology 
PKR (protein kinase R) is a 68kDa serine/threonine kinase. It is encoded 
in humans in the EIF2K2 gene. Apart from the involvement in the anti-viral 
response, dysregulation of PKR is more and more often found to be associated 
with neurodegeneration like Alzheimer’s disease (Bullido et al., 2008), 
Huntington’s disease (Peel et al., 2001), Parkinson disease (Bando et al., 2005), 
memory and learning (Segev et al., 2013, Segev et al., 2015), metabolic disorders 
(Segev et al., 2016) and cancer (Garcia-Ortega et al., 2017). 
PKR is a 551 amino acid protein which consist of two domains: an N-
terminal double-stranded RNA binding domain and a C-terminal catalytic 
domain, separated by a long ~100 amino acid unstructured region which is acting 
as a flexible linker (Meurs et al., 1990) (Figure 5a). Full PKR was never 




Figure 5. Schematic representation of the secondary structure of PKR (a), 
structure of N-terminal domain of PKR (b), structure of dimeric C-terminal 
catalytic domain (c) and complex of N-terminal domain of PKR with dsRNA 
from different views (d) 
Insight into the structure of the N-terminal domain of PKR was obtained 
with the help of 2D NMR in solution (Sambasivarao Nanduri, 1998). The N-
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terminal domain of PKR is also called dsRNA-binding domain of PKR, which 
indicates the primary function of this part of the kinase (Figure 5b). This domain 
consists of 169 amino acids which includes two 73 amino-acid long dsRNA 
binding motifs (RBM1 and RBM2) of similar structure separated by a flexible 17 
amino acid linker. The linker fits into the minor groove of the A-helix of 
dsRNA (Figure 5d). This unstructured linker region contains a high number of 
positively charged amino acids promoting the binding with the negatively 
charged phosphate backbone of the nucleic acid. The minimum calculated lengh 
of dsRNA duplex for efficient landing of PKR is between 11 and 13 nucleotides. 
The minimum length of dsRNA required for the dimerization of two PKR 
molecules is 30 nucleotides. The dimerization on top of the RNA is of parallel 
manner, where both N-termini and both C-termini are in the same plane. The N-
terminal domain of PKR is well-known to be highly specific to dsRNA structures 
and able to differentiate it from dsDNA helixes or even RNA/DNA duplexes. 
This is partly due to the length of the perfect fit of the 17 amino acid linker to the 
minor groove of the A-helix, but also due to the ability of RBMs to recognize the 
2’-OH group of the RNA.  
The C-terminal domain of PKR holds catalytic functions. The domain 
consists of N- and C-lobes placed in an angle to each other (Dey et al., 2005, Dar 
et al., 2005) (Figure 4C). The N-lobe consists of 5 anti-parallel beta-strands and 
a canonical helix (amino acids 258-369), while the C-lobe has only 2 beta-strands 
and 8 alpha-helixes (amino acids 370-551). Dimerization of PKR causes 
autophosphorylation at multiple serine and threonine sites, only a couple of which 
are located in the unstructured region and the majority is located in the C-terminal 
domain. The most well characterized phosphorylation positions are Thr449 and 




eIF2α structure and biology 
eIF2α (eIF2S1) is a 36kDa part of a heterotrimeric eIF2 complex located 
in the cytoplasm. eIF2α is a phosphorylation target of many stress-induced 
kinases. The family of eIF2α kinases, as mentioned above, includes HRI, GCN2, 
PERK and PKR (Figure65).  
 
Figure 6. Secondary structure alignment of four eIF2α kinases 
The eIF2α recognition mechanism is fully conserved across the eIF2α 
protein kinase family primarily relying on helix αG rather than conservation of 
residues on the contact surface. Sequence comparison reveals that all four 
members possess a short αF-αG helix linker and an atypically long helix αG. 
The eIF2α structure consists of an S1 subdomain (residues 3–90) flanked 
on one surface by a C-terminal α-helical subdomain (residues 91–175). This 
subdomain contains the phosphorylation site and is involved in PKR binding. The 
remaining domain is forming the complex with eIF2B and GTP during the 




Figure 7. Ribbon model of a dimerized complex of eIF2α and the C-terminal 
domain of PKR. 
eIF2α is phosphorylated in position Ser51. It has been shown that this Ser 
can be substituted for other amino acids such as Thr or Tyr and be equally 
phosphorylated (Lu et al., 1999). An eIF2α-derived target-peptide consists of 11 
amino acids 45-56: ILLSELSRRRIR (Mellor and Proud, 1991). The peptide itself 
is not a specific target to either of the four eIF2α kinases. It has been reported that 
abundant cellular kinases can cross-react with the peptide, most distinctly protein 
kinase A (PKA) (Proud et al., 1991). The specificity of the peptide recognition 
and phosphorylation comes from recognition of the helical structure on the C-
terminus of S1 subdomain eIF2α far from the phosphorylation site (in terms of 
the secondary structure) containing a conserved amino acid sequence KGYI.  
Genetically encoded FRET sensors 
Optical sensors are powerful tools for live cell research as they permit to 
follow the location, concentration changes or activities of key cellular players 
such as lipids, ions and enzymes. Most of the current sensor probes are based on 
fluorescence which provides great spatial and temporal precision provided that 
high-end microscopy is used and that the timescale of the event of interest fits the 
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response time of the sensor. Many of the sensors developed in the past 20 years 
are genetically encoded. There is a diversity of designs leading to simple or 
sometimes complicated applications for the use in live cells. A highly 
comprehensive review of all kinds of optical sensors can be found in our review 
(Bolbat and Schultz, 2017).  
We chose to focus on FRET because it allows for accurate ratiometric and 
spatiometric readout which can be helpful for studying viral infection. In brief, 
FRET is a phenomenon of energy transfer from one chromophore to another 
when they are in a very close proximity and provided the dipole moments of the 
chromophores are in the right orientation. Genetically encoded sensors are 
prepared by placing a protein-based sensing domain between a fluorescent 




Figure 8. Some examples of the FRET sensor designs. Adapted from (Bolbat and 
Schultz, 2017) 
The idea behind all FRET sensor types is to change the distance or the 
fluorophore orientation between fluorescent proteins in the presence of the 
analyte (Figure 8). One example of a sensor design is based on attaching 
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fluorescent FRET proteins to target proteins which are going to interact or 
dimerize in the presence of the substrate (“dimerization FRET”). Upon 
interaction fluorescent proteins are coming close to each other and a FRET 
readout appears. The opposite mechanism can be employed in protease FRET 
sensors, where a peptide target of protease is being cleaved and fluorescent 
proteins fall apart and the FRET readout disappears (Figure 8d).  
Another design is sandwiching a protein or a single domain of a protein 
between two fluorescent FRET proteins. Upon binding of the analyte the protein 
will change its conformation to a more closed or more opened one, which leads 
to the increase or decrease of FRET efficiency (Figure 8b). 
An example of a more complicated design approach are kinase activity 
FRET sensors. (Komatsu et al., 2011). In this case one builds a sensing domain 
out of the peptide target of a kinase connected via long polypeptide linker to a 
phospho-amino acid binding domain, followed by attaching fluorescent proteins 
on each side of the sensor. Upon activation of the kinase and phosphorylation the 
conformation of the sensor changes to a closed one which leads to appearance of 
a strong FRET readout (Figure 8a. 8c). 
The fluorescent protein FRET pair is in the overwhelming majority of 
instances CFP/YFP because of an ideal fit of their spectrophotometric properties 
to each other. It is worth mentioning that novel developments of fluorescent 
proteins with improved spectrophotometric properties lead to possible 
alternatives in the choice of fluorescent protein FRET pair. 
Aims and sensor design approaches 
The goal of the current project was to develop a FRET sensor for detecting 
the infection of RNA viruses in live cells via fluorescent microscopy. PKR and 
eIF2α were selected as the design targets for potential FRET sensors. The first 
aim (Aim 1) was to develop a working sensor based on PKR or eIF2α.  I designed 
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various different sensor models and I produced many FRET sensors. The majority 
of the developed sensors didn’t work as intended or showed unacceptably small 
readouts. However, one FRET sensor model was successful for meeting the goals 
of the project. In this thesis I will describe the idea behind the working 
prototype (named KRP1) as well as the results obtained with it. I also will briefly 
mention the other ideas for the sensor design in this paragraph and discuss them 
in more detail in the discussion section of the thesis. 
The working design for the FRET sensor was based on the N-terminal 
domain of PKR. The N-terminal domain of PKR, as described above, consists of 
175 amino acids and two RNA-binding motifs. The hypothesis was that the 
N-terminal domain of PKR changes its conformation upon binding of 
double-stranded RNA, taking a more closed conformation. I placed a pair of 
fluorescent proteins on the N- and C-terminal ends of the PKR domain. The idea 
behind the sensor was that upon double-stranded RNA binding the N-terminal 
domain of PKR will “wrap” over the double-stranded RNA, fluorescent proteins 
at the termini will come closer together and FRET will increase (Figure 8). As 
fluorescent proteins, I chose cp173Venus and mTurquoise because this pair 
worked best in previous sensors designed in the lab (Piljic et al., 2011, Stein et 
al., 2013, Bulusu et al., 2017, Kuchenov et al., 2016). 
The second aim of the thesis (Aim 2) was to optimize the sensor with the 
use of other fluorescent protein pairs from the library developed earlier in the lab 
(Piljic et al., 2011). This effective optimization approach is based on the use of 
circularly permutated fluorescent proteins. A circular permutation is a 
relationship between proteins whereby the proteins have a changed order of 
amino acids in their peptide sequence. The result is a protein structure with 
different connectivity, but overall similar three-dimensional structure. Different 
circularly permutated proteins possess different dipole moment of their 
fluorophore. Since FRET efficiency is dependent not only on the proximity but 
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also on the dipole orientation to each other (Ansbacher et al., 2012), varying the 
circularly permutated proteins in the same structure can yield significant 
improvements.  
 
Figure 9. Schematic representation of the successful FRET sensor design. 
The final aim (Aim 3) of the thesis was to test the ability of the sensor to 
detect the infection of host cells by RNA viruses. The target virus was chosen to 
be Hepatitis C. For full proof-of-concept, it was planned to use a subgenomic 
RNAHCV replicon, trans-complementary particles and full viral infection. It was 
planned to compare the result to Dengue virus infection, as this virus is of the 




Moreover, for better understanding of the PKR and eIF2α biology I will discuss 
other sensor designs used during this work but weren’t successful:  
1. Sandwiching full PKR between the fluorescent protein FRET pair to 
detect presence of dsRNA; 
2. Dimerization FRET with full PKR to detect presence of dsRNA; 
3. Dimerization FRET with N-terminal PKR to detect presence of dsRNA; 
4. Sandwiching eIF2α between fluorescent proteins to detect activity of 
PKR; 
5. Sandwiching two subdomains of eIF2α (1-120 and 13-90) which involved 
in PKR binding and contain Ser51 phosphorylation site to detect activity 
of PKR; 
6. 20 different eIF2α peptide-based phosphorylation sensors with various 






KRP1   
KRP1 construct backbone was based on a pECFP-C1 (Clontech) vector. 
mTurquoise version of CFP was introduced between the NheI and BshTI 
restriction sites (instead of the ECFP in the vector). cp173Venus version of YFP 
was introduced between the MluI and BamHI restriction sites. PKR (1-175) was 
amplified from the full PKR via a polymerase chain reaction (PCR) and 
introduced between the BshTI and MluI restriction sites (which placed it between 
the two fluorescent proteins). 
Optimization library 
One set of plasmids for the sensor optimization was constructed by PCR 
amplification of different truncated versions of PKR (1-155, 1-195, 1-215, 1-235, 
1-255, 1-275) form the full PKR sequence and introduction of them between the 
mTurquoise and cp173Venus via the BshTI and MluI restriction sites. 
Another set of plasmids for optimization was constructed based on the 
previously reported library of plasmids (Piljic et al., 2011, Stein et al., 2013), 
substituting the existing sensing domain of Camk2a or DAPK1 with PKR (1-175) 
between the BshTI and MluI restriction sites. 
Other versions of FRET sensors 
Other FRET sensors were cloned in a similar fashion to KRP1. pECFP-C1 
vector contained one of the CFP versions of the sensor between NheI and BshTI, 
one of the YFP versions between MluI and BamHI and the sensing domain 
between BshTI and MluI. As a sensing domain, I used full PKR sequence, full 
eIF2α, truncated eIF2α (1-120) and eIF2α (13-90), all amplified via PCR. 
Dimerization FRET sensor 
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Full and truncated (1-175) versions of PKR were amplified via PCR and 
introduced into the pECFP-C1 or PECFP-N1 vectors (depending on the desired 
position of the fluorescent protein: N-terminal or C-terminal respectively) 
between BshTI and BamHI restriction sites. The ECFP was substituted with the 
Venus sequence via the restriction-free cloning to obtain a second monomer for 
the dimerization FRET. 
Peptide based kinase activity sensor 
The plasmid backbone was based on previously reported EEVEE-linker 
optimized FRET sensors AKAR3EV, EKAR3EV and PichuuEV (Komatsu et al., 
2011). The phosphorylation target-peptide was substituted with one of the 20 
different versions of eIF2α (45-56) peptide between NotI and BspMII restriction 
sites. 
Cloning protocol 
The PCR amplification of the desired sequence was performed with the 
appropriate primers (purchased form Sigma) in a 3-step amplification cycle using 
a Hot-Start High Fidelity DNA polymerase from ThermoFisher according to the 
manufacturer’s protocol.  
The purification of the product was performed via 1% agarose gel 
electrophoresis (with SYBR Safe visualization intercalating agent from 
ThermoFisher) and QIAquick Gel Extraction Kit form QIAGEN. 
The restriction was done using Fast Digest restriction enzymes from 
ThermoFisher and the ligation was performed using T4 DNA ligase with a 10:1 
insert/vector ratio for 1 h at room temperature. 
The ligation mixture was transformed into the competent cells via heat 
shock according to the standard protocol. Chemically competent cells were 




The MiniPrep from the appropriate amount of bacterial culture was 
performed with QIAprep Spin MiniPrep Kit from QIAGEN, MidiPrep was done 
with the QIAGEN HiSpeed Plasmid Midi Kit and the MaxiPrep was done with 
the QIAGEN HiSpeed Plasmid Maxi Kit. 
Cell culture 
More than half of the live cell experiments were performed in HeLa Kyoto 
cells. HeLa Kyoto cells were a kind gift from Pepperkok lab (European Molecular 
Biology Laboratory, Germany). The cells were passaged and maintained at 37°C 
with 5% CO2 in DMEM consisting of 3.5 g/l glucose and 1 mM sodium pyruvate 
(Gibco), supplemented with 10% FBS (Gibco), 2 mM L-Glutamine and 0.1 
mg/mL of Primocin antibiotic (Invivogen) or a PenStrep 
(Penicillin/Streptomycin) mix (ThermoFisher). The cells were splitted 3 times per 
week in 1:5 ratio. HeLa cells were seeded in the desired dishes at 35% confluency. 
6-well plates (Nunc) contained 3*105 cells (2 ml x 1.5*105/ml), 12-well plates 
(Nunc) contained 1*105 cells (1 ml x 1*105/ml), 24-well plates (Nunc) contained 
5*104 cells (500 μl x 1*105/ml), 96-well plates (Nunc) contained 1*104 (150 μl x 
6.7*104/ml),  8-well LabTeks (ThermoFisher) 3.5*104 cells (250 μl x 
1.4*105/ml), 1-well LabTeks (ThermoFisher) 3*105 cells (2 ml x 1.5*105/ml). 
After 24 h when the cells reach 70% confluency they are used for the subsequent 
experiments. 
Huh7 cells were a kind gift from Ruggieri lab in the Department of 
Infectious diseases of Heidelberg University. Huh7 cells were maintained in the 
same medium and conditions as HeLa cells.  The cells were splitted 2 times per 
week in 1:6 ratio. Huh7 cells were seeded in the desired dishes at 50% confluency 
(due to a slower life cycle). 6-well plates (Nunc) contained 1.2*105 cells (2 ml x 
6*104/ml), 12-well plates (Nunc) contained 4*104 cells (1 ml x 4*104/ml), 24-
well plates (Nunc) contained 2*104 cells (500 μl x 4*104/ml), 8-well LabTeks 
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(ThermoFisher) 1.4*104 cells (250 μl x 6.4*104/ml). After 24 h when the cells 
reach 70-75% confluency they are used for the subsequent experiments. 
Huh7 stable cell line expressing KRP1 or KRP2 (produced in the Ruggieri 
lab) were maintained in the same conditions and seeded to the same density as 
Huh7 cells.  
Transfection 
Lipofectamine 2000 was used for the transfection of HeLa cells. The 
transfection mixture was prepared in OptiMEM or Serum free DMEM (with 
equal efficiency). The ratio of DNA plasmid to the transfection reagent was 200 
ng per 0.5 ul of Lipofectamine 2000. The protocol was followed according to the 
manufacturer’s recommendations. The amount of DNA used in different 
experiments per well was following: 200 ng in 96-well plates, 400 ng in 8-well 
LabTeks, 800 ng in 24-well plates, 1.6 ng in 12-well plates, 3-4 ng in the 6-well 
plates. The medium containing the transfection reagent was changed after 6 h of 
transfection. 24 h later the expression level was checked under the 
Olympus U-RFL-T widefield fluorescent microscope. 
Lipofectamine 3000 was used for the transfection of Huh7 cells. The 
protocol used was identical to the Lipofectamine 2000 transfection protocol with 
the only difference of adding p1000 efficiency reagent together with the plasmid 
DNA in the amount equal to the Lipofectamine 3000 reagent (according to the 
manufacturer’s protocol). 
Native cell lysis 
Cells of choice (HeLa, HEK293T or Huh7) were seeded in 6-, 12- or 24-
well plates at 35 % confluency. In 24 h when the confluency reached 70% cells 
were transfected with the desired sensor plasmid according to the previously 
described protocol. After the next 24 h the medium was aspirated and the cells 
were kept on ice for all the following steps. Cells were gently washed twice with 
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2, 1 or 0.5 (depending on the cell culture dish) ml of ice cold PBS. After aspirating 
the excess PBS, I added RIPA buffer from ThermoFisher (150 mM NaCl, 50 mM 
Tris, pH=8.0, 1% of NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 
supplemented with cOmplteTM protease and phosphatase inhibitor cocktail from 
Roche and 1 mM PMSF from Sigma) in the amount of 10% of the cell culture 
medium volume (200 μl, 100 μl or 50 μl depending on the cell culture dish). Due 
to the potential drying of the buffer after the 15 min incubation time, not more 
than 6 wells can be handled at the same time. After the 15 min incubation 
successful lysis procedure can be identified by eye because of the appearance of 
membrane remainings aggregating with each other. Cells were scrapped using 
cell scrappers (one scrapper per well) and the lysate was transferred in the 1.5 ml 
eppendorfs. The samples were centrifuged at 13,000 x g for 15 minutes at 4°C. 
Finally, the supernatant was transferred into the new tubes, aliquoted and stored 
at -40°C. If using the lysates within a week, aliquoting step can be omitted. The 
lysates can be stored at +4°C for 3 days or one week with 0.01% NaN3 before 
significant protein degradation.  
Fluorimetry 
The lysates from the 6-well plates were transferred into the Fluorimeter 
Micro Square Cells (black cuvettes for fluorescence measurements) from Thomas 
Scientific. The excitation and emission spectra were collected in the JASCO 
FP-8300 spectrofluorometer. 
Calibration was done by collecting the spectra of the blank solution (lysate 
of untransfected Hela or Huh7 cells in RIPA buffer). Obtained wavelength 
intensities were subtracted from the corresponding wavelength intensities in 
collected excitation or emission spectra.  
The excitation and emission spectra of individual fluorescent proteins were 
measured before each experiment as a quality control to confirm the presence of 
these fluorescent proteins in the sensor. 
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The “FRET” excitation spectra were collected at a constant wavelength of 
the acceptor fluorescent protein. The appearance of two peaks (both acceptor and 
donor) indicates the presence of FRET. 
The “FRET” emission spectra were collected at a donor fluorescent protein 
excitation wavelength. The appearance of two peaks (both donor and acceptor) 
indicates the presence of FRET and the ratio of the acceptor emission to donor 
emission in this mode is used as a FRET readout. 
CFP/YFP FRET. mECFP/mTurquoise excitation spectra were collected 
in the range of 400-470 nm at a constant 475 nm emission wavelength, FRET 
(CFP/YFP) excitation spectra were collected in the range of 400-520 nm at a 
constant 527 nm emission maximum, Venus excitation spectra were collected in 
the range of 500-520 nm at a constant 527 nm emission maximum.  
mECFP/mTurquoise emission spectra were collected in the range of 
460-500 nm with the 435 nm excitation wavelength. FRET (CFP/YFP) emission 
spectra were collected in the range of 460-540 nm with the 435 nm excitation 
wavelength. Venus emission spectra were collected in the range of 520-540 nm 
with the 515 nm excitation wavelength. 
GFP/RFP and YFP/RFP FRET. mClover3 (green) excitation spectra 
were collected in the range of 450-510 nm based on 518 nm emission maximum, 
Venus/SYFP2/YPet excitation spectra were collected in the range of 450-520 nm 
at a constant 527 nm emission maximum, FRET (GFP or YFP/RFP) excitation 
spectra were collected in the range of 450-585 nm at a constant 594 nm emission 
maximum, mScarlet excitation spectra were collected in the range of 540-585 nm 
at a constant 594 nm emission maximum.  
mClover3 emission spectra were collected in the range of 510-560 nm with 
the 506 nm excitation wavelength. FRET (GFP or YFP/RFP) emission spectra 
were collected in the range of 510-610 nm with the 506 (green) or 518 (yellow) 
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nm excitation wavelength. mScarlet emission spectra were collected in the range 
of 575-610 nm with the 569 nm excitation wavelength. 
Trypsin digestion. Before the treatment of the sensor with the substrate 
(separately) and in the end of the experiment I added 10 μM recombinant trypsin 
(Sigma) to the lysate as a control for FRET (which lead to the disappearance of 
the FRET peak and increase in the donor fluorescence). 
In vitro analysis of the FRET sensor library 
The measurements were done in Nunc F96-well black plates with the 
Tecan the Infinite m1000 pro plate reader. 
The HeLa cells were seeded and grown in the 96-well plates till 70% 
confluency. The cells were transfected with each of the plasmid from the 
optimization library with Lipofectamine 2000 in quadruplicates and lysed after 
24h. 100 ng of dsRNA or polyI:C was added in the two of the well per plasmid. 
The intensity of emitted fluorescence was measured at the 435 nm excitation in 
the range of 470-480 (CFP peak is at 475 nm) and 522-532 (YFP peak is at 527 
nm). The background was measured in untransfected HeLa lysate and subtracted 
from the corresponding sensor measurements. The ratio from the corrected 
average YFP intensity to corrected average CFP intensity was taken as a FRET 
readout. 
Plasmid DNA spotting 
Spotting of DNA plasmid transfection mixture and the reverse transfection 
was performed according to the previously described protocols (Piljic et al., 2011, 
Kuchenov et al., 2016, Stein et al., 2013, Bulusu et al., 2017). Plasmids used in 
this assay were all obtained from the MaxiPrep. To prepare the transfection 
mixture, 9 μL of a 0.4 M sucrose solution in DMEM, 9 μL of DNA and 33 μL of 
Lipofectamine 2000 were mixed in a 96-well plate. After 20 min incubation at 
room temperature, 21.75 μL of solution of 0.29% gelatin in water was added to 
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the mixture, and 24 μL of the transfection cocktail was distributed in 384-well 
plates. Subsequently, a plate was centrifuged briefly up to 54×g at room 
temperature to straighten the surface of the samples and placed immediately in 
the contact printer. Before printing, LabTek dishes were washed with 70% 
ethanol to increase the hydrophobicity of the LabTek surface and, accordingly, to 
improve the shape of the spots. One-well LabTek dishes were printed with a 
“ChipWriter” contact printer equipped with solid pins. Using PTS 600 pins, the 
diameter of printed spots was about 400 μm and the spot-to-spot distance was 
1.125 μm. Printed 1-well LabTek dishes were stored at room temperature in a 
gel-drying box in the presence of drying pearls. Each FRET construct from the 
“optimization library” was printed in quadruplicate per one LabTek. Before the 
experiment, HeLa were seeded in these 1-well LabTeks containing the plasmid 
“spots” at 30% confluency. When the confluency reached 60-65% 24 h later, the 
cells were imaged upon addition of dsRNA.  
RNA transfection 
Short dsRNA 30 bp duplex was obtained via annealing of ssRNA 
components purchased from Sigma. I used previously reported (Lemaire et al., 
2008) ssRNA sequences: 5’-GGAGAACUUCAUGCCCGUCGGAUAAGACU-
3’ and 5’-AGUCCUUAUCCGAAGGGCAUGAAGUUCUCC-3’. 
Long 200 bp dsRNA was obtained via annealing of the ssRNA components 
provided by the Ruggieri lab. The ssRNA components were the first 200 
nucleotides of the Ampicillin sequence obtained via in vitro transcription. 
Annealing was performed by mixing equal amounts of ssRNA in the 
annealing buffer (10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA), placing the 




PolyI:C of low molecular length (LMW), polyI:C of high molecular weight 
(HMW) and polyA:U were purchased from the Invivogen. 
For the experiments in HeLa cells, 200-500 ng of dsRNA (in 15 μl of the 
Imaging Buffer (IB): 115 mM NaCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 
1.2 mM K2HPO4, 0.2% glucose and 20 mM HEPES, pH 7.4) was mixed for 20 
min with 0.5-1.25 μl of Lipofectamine 2000 (in 15 μl of the Imaging Buffer (IB). 
Before the imaging under the microscope, the dsRNA mixture was added into the 
well of the 8-well LabTek chamber containing cells expressing the FRET sensor. 
The negative control experiment was performed with the addition of the “empty” 
transfection reagent (without dsRNA). 
For the experiments in Huh7 cells, the Lipofectamine 3000 was used to 
transfect the dsRNA (additional p1000 reagent was premixed with the dsRNA 
before the addition to the Lipofectamine 3000). Other than that the protocol was 
identical to the one described above.  
Single-stranded viral subgenomic RNAHCV replicon was produced in the 
Ruggieri lab according to the previously described protocol (Schult et al., 2018) 
and kindly provided to me. 100-200 ng of dsRNA was premixed with 0.5 μl of 
p1000 (from Lipofectamine 3000 kit) in 10 ul of  IB. After 10 min this solution 
was added to the 10 ul of IB containing 0.75 μl of Lipofectamine 3000. Following 
the 15 min incubation time, the dsRNA mixture was added into the well of the 8-
well LabTek chamber containing Huh7 cell stably expressing the FRET sensor. 
The imaging began after 12 h of transfection. 
Solutions containing ssRNA was kept in ice at all times. Before handling 
the ssRNA, the workplace was always treated with RNaseZap Decontamination 
Solution from ThermoFisher. 
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Stable cell line production 
The stable cell line of Huh7 cells expressing the designed FRET sensor 
was produced by Philipp Klein from the Ruggieri lab. It was done based via 
lentiviral transduction described previously (Schult et al., 2018). 
Infection 
The infection with trans-complementary particles of HCV (TCPHCV) and 
Dengue virus (DENV) was performed in the Biological Safety 3 lab at the 
Heidelberg University Clinic with the help of Philipp Klein from the Ruggieri lab 
according to the previously described protocols (Ruggieri et al., 2012, Chatel-
Chaix et al., 2016, Schult et al., 2018).   
Microscopy 
All cell experiments were performed in the Imaging buffer: 115 mM NaCl, 
1.2 mM CaCl2, 1.2 mM MgCl2, 1.2 mM K2HPO4, 0.2% glucose and 20 mM 
HEPES, pH 7.4. In all cases, LabTeks with the cells were placed in the 
microscope environmental box at 37°C (and no CO2). The overwhelming 
majority of imaging experiments were performed using confocal fluorescent 
microscopes: Olympus FluoViev1200 and Zeiss LSM 789 NLO.  
Olympus FV1200. Imaging was performed on a FluoView1200 (catalog 
#IX83; Olympus) confocal laser-scanning microscope at 37°C (incubator box 
made by the European Molecular Biology Laboratory), using Olympus 20× 
UPLSAPO (numerical aperture 0.75, air) objectives and FluoView software, 
version 4.2. The images were acquired with a Hamamatsu C9100-50 EM-CCD 
camera. The cyan and FRET channels was imaged using a 405-nm laser line (120 
mW/cm2, 5%) with the 460-500 (cyan) nm and 510-560 (yellow) nm emission 
range respectively. The red channel was imaged using a 559-nm laser (120 
mW/cm2, 2.0%) and a 643/50 emission filter. Images were acquired in 15-s 
intervals. The dual scanner setup allowed for simultaneous laser stimulation and 
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confocal imaging. This permitted the acquisition of cellular responses that occur 
during or immediately after laser stimulation. 
Zeiss LSM 789 NLO. Confocal microscopy was performed using a Zeiss 
LSM 780 NLO confocal microscope at 37°C, equipped with a 20x Plan-
Apochromat 20x/0.8 M27 objective. Definite Focus (Carl Zeiss) was used to 
minimize focus shifts during time-lapse experiments. Excitation and emission 
settings were similar to the ones described above. 
At the end of each imaging experiment the control acceptor photobleaching 
was performed in several selected cells in the field of view. This lead to vanishing 
of acceptor fluorescence and increase in the donor fluorescence in the target cells 
as a proof of FRET. 
Olympus IX83. All the imaging related to the reverse transfection 
experiments with the “optimization library” were performed in the widefield 
fluorescent microscope due to the speed of imaging (fluorescent lamp 
illumination of the whole specimen instead of scanning in the confocal mode) and 
higher intensity of fluorescence (due to the absence of the pinhole compared to 
the confocal microscopes). The microscope was equipped with a Hamamatsu 
ImagEM CCD camera and an environmental chamber using 20× 0.70 numerical 
aperture (NA) or 10× 0.40 NA and 436/20 excitation filter, a CFP/yellow 
fluorescent protein (YFP) dual-band beam splitter (51017bs; Chroma), and two 
emission filters (470/30 for CFP and 535/50 for YFP) that were controlled by a 
filter wheel. The images were captured with xCELLence software at 3 min 
interval. 
Nikon Eclipse Ti. Infection experiments were performed in the Biological 
safety level 3 lab at the Heidelberg university clinic using a Nikon Eclipse Ti 
inverted microscope using a 40× Plan-Apo N.A. 0.95 objective (Nikon). Forty to 
60 observation fields were defined, and image acquisition was performed at 
intervals of 1 h for 48-72 h by using the automated Nikon perfect focus system, 
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435 nm excitation with CFP and YFP filters, together with 570 nm excitation with 
mCherry filters. Images were analyzed with the Nikon NIS Element Advanced 
Research program and processed by using the image processing package Fiji. 
Image analysis 
Images were analyzed using FIJI, a distribution of ImageJ with the help of 
previously designed macro for FRET readout analysis - FluoQ (Stein et al., 2013). 
FIJI is the recommended ImageJ distribution for FluoQ, since the macro makes 
use of several plug-ins that come with FIJI, but not with plain ImageJ. The 
following processing options were chosen within the macro: the background was 
subtracted using ImageJ’s built in function. A median filter (radius size = 2) was 
used to smooth the images. Before calculating the ratio channel, images were 
transformed to 32-bit float and a threshold was applied to remove low value pixels 
from analysis. Cells were segmented automatically by FluoQ using the 
histogram-based “Triangle” threshold algorithm to create a binary cell mask, the 
watershed algorithm to separate cell clumps, and finally the particle analyzer 
plug-in to define ROIs. FluoQ measured the mean pixel intensity of each ROI 
over time and saved all measured data and calculated parameter in a text 
file (EXPNAME_data set.txt) that was subsequently loaded into the R program 
in order to do the data analysis. Plots were produced using the gglot2 R package. 
Western blot 
HeLa cells were split and grown in 6-well plates or individual 35mm cell 
culture dishes to a confluency of 70%. After 24h they were transfected with target 
FRET sensors using Lipofectamine 2000 and cultured for 24 h. Cells were 
harvested using a cell scraper and lysed according to the previously described 
protocol.. Lysates (50 mg) were separated on NuPAGE 4-12% Bis-Tris protein 
gels (10-well, ThermoFisher) in the X-Cell SuperLock Mini-Cell and transferred 
to PVDF membranes (Immobilon-P, Millipore), with the help of X-Cell II Blot 
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modules the following the manufactures’ protocol. Afterwards, the membranes 
were blocked using 5% skim milk in a standard PBS-T buffer (or 5% BSA in a 
standard TBS-T buffer when using the antibodies against phosphorylation). The 
primary antibodies were incubated in 5% skim milk overnight. The HRP-
conjugated secondary antibodies were incubated for 1 h and imaged using a Bio-
Rad imaging system 
Antibodies used were purchased from: 
1. Loading control Abcam mouse anti-βactin, ab 6276; 
2. Primary Abcam rabbit anti-eIF2α (pS51), ab 32157; 
3. Primary Abcam rabbit anti-PKR (pT446), ab 32036; 
4. Primary ThermoFisher mouse anti-eIF2α, QF215110; 
5. Primary ThermoFisher rabbit anti-PKR, 810467 a; 
6. Secondary ThermoFisher goat anti-rabbit IgG (H+L), HRP conjugated, 
AB_10960844; 






Fluorometric analysis of the FRET sensor 
As was previously mentioned, in the sensor I exploited the ability of the 
N-terminal domain of PKR to bind dsRNA during the infection of RNA viruses. 
I cloned a FRET sensor which consists of mTurquoise (version of CFP), N-
terminal domain of PKR (PKR1-175) and cp173Venus (version of YFP with a 
circular permutation). At first, sensor had to be proven to produce a FRET 
response in the presence of dsRNA. For that, I expressed KPR1 in HeLa cells, 
next day the cells were lysed in the native conditions and the lysate containing 
the expressed KPR1 was transferred to the cuvette for the fluorescent 
measurements. I decided to perform the measurements in the lysate, as oppose to 
purifying the KRP1 protein. The reason behind it is a more native environment 
of the sensor in the cell potentially including some internal double-stranded RNA 
molecules that the sensor can bind to. Another reason is the simplicity of the lysis 
procedure compared to the protein purification methodology. 
To obtain the FRET readout, I collected emission spectra of the lysate 
containing KPR1 with or without the presence of the substrate (dsRNA) while 
exciting only mTurquoise (CFP, one of the exc. max - 435 nm). In this excitation 
mode, a presence of the second peak of corresponding to YFP indicates energy 
transfer during FRET. The ratio of the intensities of two peaks was taken as a 
FRET readout. Titrating the lysate with 30 bp dsRNA duplex (reported previously 
in PKR-RNA studies) resulted in the increase in FRET ratio (Figure 10). This 
experiment clearly indicates that upon the dsRNA binding, the sensor adapts a 
more close conformation, fluorescent proteins come closer together and the FRET 




Figure 10. Emission spectra of KPR1 during the titration with dsRNA. 
 
 




To prove that the second peak appears due to FRET and not a cross-
excitation of YFP, the lysate containing KPR1 or the lysate containing KPR1 after 
addition of saturating amount of dsRNA was treated with trypsin. We observed 
that the beta-barrel structure of the fluorescent proteins and also proteins’ 
chromophores are more resistant to the trypsin digestion, we observed FRET to 
vanish due to the separation of FPs of KPR1 from each other (Figure 12). 
 
Figure 12. Emission spectra of KRP1 before and after the addition of trypsin. 
PKR was reported to bind RNA sequence-independently. To test that we 
treated the lysate containing KPR1 with polyI:C mix. PolyI:C is a polymer mix 
of  a varying lengh (LMW – low molecular weight: 100-1000 bp duplexes; HMW 
– high molecular weight: 1000-10000 bp duplexes) which maintains a dsRNA A-
helix structure (Figure 13). PolyI:C is commonly used to mimic the responses to 
infection of RNA viruses by activating the interferon response. Treatment with 
polyI:C resulted in the same FRET increase as with 30 bp dsRNA (Figure 14). 
The saturation curve looked similar indicating that one long RNA molecule can 
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bind many KPR1 units. I tested the polyA:U mixture and the 200 bp RNA duplex 
of first 200 nt of Ampicillin sequence and obtained the same result. 
 
Figure 13. Structure of one I:C nucleotide pair. 
 
 
Figure 14. Emission spectra of KPR1 during the polyI:C treatment. 
Specificity of the sensor 
Next step was to test the specificity of KPR1 to the dsRNA substrate. 
Previous reports suggested that PKR is extremely specific to  the dsRNA 
structure, able to differentiate it not only from ssRNA, ssDNA and dsDNA, but 
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also from RNA/DNA duplexes. We treated the lysate containing KPR1 with 
ssRNA, ssDNA and dsDNA of different length and observed no FRET change in 
the fluorescent spectra (Figure 15 and 16). As a control, dsRNA was added at the 
end of the experiment to induce the FRET response. 
 
Figure 15. Emission spectra of KPR1 during titration with ssRNA, 




Figure 16. FRET ratio changes of the sensor depending on the substrate 
 
Performance of the sensor in live cells 
After designing the dsRNA sensor and confirming a quite good FRET 
response to dsRNA in vitro I wanted to test the performance of KRP1 in live cells 
against dsRNA. The difficulty of this experiment is inefficient delivery of the 
RNA inside the cell. dsRNA is negatively charged and cannot pass thorough the 
cell membrane. Among several nucleic acid delivery methods (including the 
electroporation and microinjection) the transfection was chosen for the 
experiments. 
I expressed KRP1 HeLa cells. Despite the variability in the fluorescence 
intensity among different cells due to the transfection process, the FRET ratio in 
all cells was the same. The sensor localization was predominantly cytoplasmic, 
thus, providing the “negative” nuclear staining helping to clearly identify (and 
later process during the image analysis) cells during the imaging. Transfection of 
the short 30 bp dsRNA duplex caused cells to have a high FRET ratio compared 
to the cells transfected with the empty transfected reagent (Figure 17). The time 
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when the FRET response can be observed begins after 5h (the time needed for 
the RNA/transfection reagent complex to move inside the cell) (Figure 18). 
Acceptor photobleaching performed in some individual cells recovered the CFP 
fluorescence in them, while disposing of the YFP signal. This routine control 
confirms FRET and eliminates YFP cross-excitation and CFP bleed-through 
artifacts. It is hard to see cells with high FRET during the imaging of the cells 
later than 8h after RNA transfection. This is due to a high rate of the cell death 
because of both the transfection reagent and, even more so, the transfected RNA. 
In fact, the FRET in the cells begins to drop even below the level of the untreated 
cell. As surprising as it might seem, this is a common feature of many FRET 
sensors which respond to substrates with the FRET increase (Hochreiter et al., 
2015). The activation of unspecific proteases during the apoptosis causes the 
digestion of the sensor and the separation of two fluorescent proteins and, hence, 
loss of FRET. The digestion of the fluorescent proteins themselves takes a much 
longer time, so individual fluorescence remains up until the cell membrane 
collapses. 
As expected, the transfection of 200bp dsRNA, polyI:C (LMW), 
polyI:C (HMW) and polyA:U caused the transfected cells to have a higher FRET 
ratio, proving that the KRP1 response is not dependent on the sequence of the 
dsRNA (Figure 17). The toxicity in case of the big polyI:C molecules is much 
stronger than in the case of the short dsRNA duplexes which can be identified by 




Figure 17. Mean FRET/CFP ratio across several HeLa cells expressing KRP1.  
 
Figure 18. Example of FRET/CFP ratio images of HeLa cells expressing KRP1 
in the absence or presence of dsRNA after 5h of transfection. 
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Optimization of the sensor 
Optimization of the insert part 
A standard procedure during the development of any sensor is an 
optimization of its performance. In KRP1 I pursued two optimization targets: 
RNA-binding part and fluorescent protein part. 
RNA-binding part consists of the N-terminal domain of PKR (PKR 1-175). 
This RNA-binding domain is followed by a ~100 amino acid unstructured region 
before the catalytic C-terminal domain begins. The idea was to add amino acids 
from this unstructured region to the original PKR (1-175) with the step of 20. 
Effectively I was adding a long linker between the PKR part and one of the 
fluorescent proteins with the hope to reduce initial FRET in the resting 
conformation and, thus, increase the dynamic range of the sensor (Figure 5). Also 
I decided to take away 20 amino acids from the RNA binding domain to make 
the conformation stiffer with the hope of increasing the FRET change during the 
dsRNA binding (which would also increase the dynamic range of the sensor). 
The sensors containing PKR 1-155, PKR 1-175 (KRP1, the original 
version), PKR 1-195, PKR 1-215, PKR 1-235, PKR 1-255 and PKR 1-275 were 
titrated with the increasing amount of dsRNA and the emission spectra were 





Figure 19. Emission spectra of KRP1 containing different length of the N-
terminal domain of PKR upon dsRNA treatment. 
The sensors with the “long linker” had indeed lower initial FRET in the 
absence of dsRNA (the longer the linker was – the lower FRET was detected). 
Unfortunately, addition of the substrate didn’t result in any FRET change of the 
construct. The only version which showed a FRET response was the PKR(1-195) 
construct (20 amino acids longer N-terminal domain of PKR than in the original 
KRP1) with the maximum FRET ratio change of 27% (Figure 20). The dynamic 
range appeared to be lower than in the PKR (1-175) version, therefore the original 
version of the sensor had the optimal RNA sensing par. The PKR(1-155) version 
(lacking 20 amino acids from the C-terminal part of the dsRNA binding domain 
of PKR) had a significant “initial FRET” in the absence of the RNA, but didn’t 
show any FRET change after the addition of the substrate, hence, no RNA 
binding. This indicates that both RNA binding motifs of the N-terminal domain 
of PKR are important for binding dsRNA (even partly truncating one of them 





Figure 20. Max FRET ratio change of KRP1 containing different length of the 
N-terminal domain of PKR upon dsRNA treatment 
 
Optimization of the Fluorescent protein FRET pair 
In the sensor design I employed the most common and optimal CFP/YFP 
fluorescent protein FRET pair. Fluorescent proteins’ proximity and orientation to 
each over is limited by the conformation of the sensor part of the sensor (which 
is the N-terminal domain of PKR). Addition of the flexibility factor in the 
fluorescent proteins’ positioning via introduction of the linkers is not a successful 
strategy as concluded from the previous experiments. Alternative way to change 
not the proximity but the orientation of fluorescent proteins is to use their 
different circularly permutated versions (briefly discussed in the introduction 
section) in the sensor. Introduction of different circularly permutated versions of 
one of the fluorescent proteins can change the orientation of the fluorophore 
dipole moments to, hopefully, a more optimal one, and the use of different 











155 175 195 215 235 255 275
Dynamic range of the FRET sensors
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This idea was exploited in our lab some time ago to design new and 
improve the existing FRET sensors (Kuchenov et al., 2016, Bulusu et al., 2017, 
Piljic et al., 2011, Stein et al., 2013). We cloned a library of plasmids containing 
different circularly permutated versions of Venus (as yellow fluorescent protein), 
different versions of cyan fluorescent protein and a 2-, 4- or 8-amino acid linker 
between them with an easy way to introduce the insert of interest. 
The method is designed for a high throughput screening of FRET sensors 
inside the live cells. All of the cloned sensors from the library are “spotted” on 
the coverslip mixed with the transfection reagent followed by the reverse 
transfection into the cells seeded on top of the plasmids. The sensors are imaged 
under a fluorescent microscope (desirably with a fast stage) during the treatment 
with the small molecule substrate. 
I cloned a set of 36 sensors (coded F02-F63, Figure 21) and tried to test 
them with the original protocol. Unfortunately, the live cell imaging after spotting 
was not suitable for comparing sensor performances. The variability in the 
amount of transfected RNA from cell to cell and long time-intervals of imaging 
(up to 8h) made it hard to clearly decide about the performance of the individual 
sensors compared to each other. The majority of FRET sensors (and our published 
optimization approach) are designed against small molecules, well diffused and 





Figure 21. A list of the codes and FRET pairs used in the library (green – original 
KRP1, red – sensors which show a much higher FRET response). 
This forced me to find another testing approach. Ultimately, I designed a 
high-throughput in vitro assay to test my sensor library. The plasmids were 
transfected in a high-throughput manner into the cells seeded in the 96-well plate. 
This was followed by the native lysis of the cells and measurement of the CFP 
and FRET fluorescence in the presence and the absence of dsRNA in each well 
with the plate-reader. In this way we determined FRET ratio change of each 





Figure 22. Dynamic range of all of the FRET sensor versions obtained from the 
library (green – original KRP1, red – sensors which show a much higher FRET 
response). 
Interestingly enough, 2-amino acid linker worked best with every 
fluorescent protein pair while 4- and, even more so, 8- amino acid linker reduced 
the dynamic range. Fortunately, I identified several sensors having higher FRET 
ratio change in the presence of dsRNA than the original KRP1 (coded F40 in the 
library). Due to some margin of error of the pate-readers (because of measuring 
the fluorescence in small volumes) I expressed some of the best identified sensors 
and tested them in the cuvette (Figure 23). The best performance was observed 
for a sensor with the pair coded under the name F02, containing mECFP 
(interestingly not mTurquoise), wild type version of Venus and a two amino acid 




Figure 23. Emission spectra of some of the chosen FRET sensors collected in the 
fluorimeter (F40 – original version, F02 – the best version, blue line – before the 
addition of dsRNA, orange line – after the addition of dsRNA). 
 
 
Figure 24. Dynamic range of some of the chosen FRET sensors (F40 – original 
version, F02 – the best version). 
57 
 
Performance of the improved sensor in live cells 
After the optimization step I identified several fluorescent protein pairs 
which improved FRET response of the sensor. The best FRET efficiency in the 
current setup was achieved with ECFP (with the monomeric mutation) and a 
wild-type version of mVenus (no circular permutation). The optimized version of 
the sensor (with the FRET pair coded F02 in the previous figure) was called 
KRP2. I subjected KRP2 to the same dsRNA tests which were performed on the 
original version of the sensor. 
The HeLa cell lysate containing expressed KRP2 was treated with the 
dsRNA while collecting the emission spectra of the sensor. The improved sensor 
has a maximum FRET ratio change of 93% when saturated with dsRNA which is 
more than double of the original KRP1 (Figure 25). A control treatment with 
trypsin destroyed FRET and recovered the original CFP intensity and treatment 
with different polyI:C versions resulted in identical emission spectra. 
 
Figure 25. Emission spectra of KRP2. 
58 
 
The specificity of KRP2 was not expected to be different from the original 
version, but nevertheless was worth checking due to higher sensitivity of KRP2. 
The response during treatment with dsDNA, ssDNA and ssRNA was scornfully 
low (Figure 26). 
 
Figure 26. FRET ratio changes of the KRP2 depending on the substrate. 
KRP2 was also tested in live HeLa cells under the microscope against the 
treatment with dsRNA.  Fortunately, FRET ratio of the sensor among untreated 
cells was constant and didn’t vary despite more than twice higher sensitivity 
compared to KRP1. Treatment with dsRNA resulted in many cells having a 
higher FRET ratio compared to the cells treated with empty transfection reagent, 
in often reaching maximum possible FRET ratio change. A routine acceptor 




Huh7 stable cell line expressing the sensor 
In order to test the sensor against a viral infection it has to be introduced 
into the system where the replication of HCV is possible and efficient. The 
commonly used system for studying HCV is Huh7 cell line, which was picked 
for the current project.  
Testing and using the sensor in the pipeline developed for HeLa or HEK 
cells was proven to be problematic. Huh7 cells appeared to be stiff and quite 
resistant to the introduction of the sensor plasmid either by transfection or 
electroporation. With the use of strong transfection reagents like Lipofectamine 
3000 I managed to transfect Huh7 cells with KPR2 and successfully test it against 
dsRNA or polyI:C either in the lysate in vitro or on the cover slip in vivo (data 
not shown). However, high toxicity and low efficiency of this approach in the 
Huh7 cells forced us to develop a stable cell line expressing the sensor.  
The stable cell line was produced in the Ruggieri lab and was kindly 
provided to me. Another potential advantage of using a stable cell line is a much 
lower expression level of the sensor inside the cell which would lead to a larger 
FRET readout in the case of low quantity of dsRNA produced during viral 
infection. 
A quality control of the cell line was performed in a similar fashion to the 
one in HeLa cells. The Huh7-KPR1 or Huh7-KRP2 cells were lysed in the native 
conditions and the emission fluorescent spectra were obtained during the 
treatment with dsRNA or polyI:C (Figure 27). As expected, spectra looked the 
same as in the case of HeLa cell lysates, FRET ratio change was similar to what 




Figure 27. Emission spectra of the lysates of Huh7 stably expression KRP1 (a), 
KRP2 (b) and max FRET ration change upon addition of dsRNA. 
Under the microscope, the fluorescent intensity and the FRET ratio were 
universally distributed with no cell-to-cell variability, as was observed in case of 
HeLa or HEK cells. Transfection of the short dsRNA resulted some cells having 
a higher FRET ratio (Figure 28). Unfortunately, the maximum potential of the 
FRET ratio change was not reached because of poor efficiency of dsRNA 
transfection. Increase in the amount of either the transfection reagent or dsRNA 
causes significant cell death. Transfection of polyI:C was also inefficient and 
even more toxic for the cells,, although the cells with a higher FRET ratio were 




Figure 28. Example of FRET/CFP ratio images of Huh7 cells expressing the 
sensor in the absence or presence of dsRNA after 5h of transfection. 
 
 
Figure 29. Mean FRET/CFP ratio across several Huh7-KRP2 cells upon the 
transfection of dsRNA  
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Worth mentioning that the dsRNA (or rather polyI:C) treatment doesn’t 
induce the interferon response in Huh7 cells which would lead to overexpression 
of the endogenous PKR. While it is irrelevant in the experiments involving RNA 
transfection or electroporation, lower quantities of the endogenous PKR can 
improve the sensitivity of the sensor in the presence of low amounts of viral RNA. 
Viral subgenomic RNA replicon transfection 
Following the successful validation of the Huh7 stable cell line expressing 
the KPR1 I started to move towards the direction of viral infection. As a first step 
of proof-of-concept, KPR1 was tested against self-replicating subgenomic HCV 
replicon   (Lohmann et al., 1999). This viral RNA of roughly 4.5 kb was cloned 
and kindly provided to me by Ruggieri lab (Figure 30). This RNA can replicate 
itself since it encodes HCV “replication” proteins, thus producing dsRNA 
intermediate during the replication. The main advantage of the use of this 
subgenomic replicon is inability to produce new full viral particles (due to the 
lack of structural genes in the RNA) hence being safe for the experiments.  NS5A 








I transfected the stable cell line with KRP2 with moderate amount of HCV-
RNA and imaged the cell on the next day. At certain period of time I could 
observe cells which were transfected with the HCV-RNA (and hence expressing 
mCherry) and having a much higher FRET ratio than the non-treated ones (up to 
the level of cells transfected purely with dsRNA) (Figure 31). The results were 
very promising, since it proves that the amount of dsRNA intermediate produced 
during the replication is sufficient to force the sensor response (Figure 32). 
Another pleasant observation was that this single-stranded viral RNA in the 
quantities comparable to dsRNA doesn’t produce any FRET readout even though 
this RNA has some double-stranded hairpins structure parts. Potential reason for 
that is binding of host and viral proteins or ribosomes which shields these regions 
from the sensor. Finally, the endogenous PKR present in cells does not 
significantly interfere with the sensor binding to the RNA. 
 
Figure 31. Example of FRET/CFP ratio images of Huh7 cells expressing the 






Figure 32. Mean FRET/CFP ratio across several Huh7-KRP2 cells (n=24 and 
n=15 respectively) after the transfection with 100 ng of the subgenomic RNA 





Figure 33. Mean FRET/CFP ratio of the Huh7-KRP2 cells upon transfection of 
different amount of the RNAHCV replicon 
However, there are couple of issues to mention in regard to the use of this 
HCV-RNA. Firstly, the FRET readout of the sensor is bell-shaped. Significant 
FRET ratio change can be observed only at a specific point of time around 30 h 
after transfection (Figure 33).  
66 
 
Secondly, the transfection of the cells with HCV-RNA is not simultaneous. 
Appearance of mCherry signal indicates the translation of the viral RNA when it 
is inside the host cell, and the signal appears in different cells at different time, 
resulting in up to 4-5 h variability. Another source of variability comes from 
different individual amounts of the transfected RNA form cell to cell (due to the 
imperfections of the transfection method). All of the sources of variability make 
it challenging to determine the kinetics or, rather, the precise time of optimal 
sensor readout. 
Interestingly, transfection of the high amounts of HCV-RNA (larger than 
200 ng of RNA per ~2.5*104 of cells) results in no FRET readout at all and high 
rate of cell death within 36h (Figure 33).  
After a certain period of time (depending on the amount of RNA 
transfected) I can observe the cell death which is indicated by lower FRET 
readout compared to the non-treated cells. 
Viral infection 
Moving one step further, I decided to test the sensor against the infection 
of HCV trans-complementary particles (TCPs). These particles are a single-round 
infectious virus containing the truncated genome which lacks necessary structural 
genes to produce a new particle during the replication (Adair et al., 2009, 
Steinmann et al., 2008, Ishii et al., 2008). TCPs are produced by expressing HCV 
structural proteins in “trans” in packaging cell lines (Huh7) complemented with 
the HCV replicon (mentioned in the previous chapter). In simple words, TCPs 
are a full virus with the truncated genome and, therefore, unable to produce new 
particles after the infection. The advantage of using TCPs over the full virus is 
non-infectivity, which makes working with them more convenient. The infection 
with the TCPHCV requires only biosafety level 2 labs (BS2) as opposed to BS3 lab 
requirement of the full HCV infection. After washing step on the following day, 
the previously infected cells are permitted to handle anywhere. The advantage of 
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using TCPs over the transfection of the subgenomic replicon of HCV is 
resemblance of the cell entry properties of the full virus. Another appealing 
feature of using TCPs for the infection is the potential accumulation of the 
replicated viral RNA (due to inability to produce new virions) and, hence, better 
chance of the KRP2 succeeding in sensing the dsRNA intermediate. 
As was the case in the HCV replicon experiment, after the infection of the 
stable Huh7 cell line expressing KRP2 with TCPHCV at a certain period of time I 
observed cells with a higher FRET ratio compared to the non-infected 
cells (Figure 34). Behavior of the cells and the sensor was similar to one in case 
of the HCV replicon experiment, although the kinetics was different. The FRET 
readout also was a bell-shaped curve. The time point when I observe a FRET ratio 
increase was around 48 h after the infection (24 h after the beginning of the 
imaging under the microscope) (Figure 35).  As an additional control, cells were 
infected with the TCPs but also treated with the HCV replication inhibitor, 
resulted in no FRET change in the cells and no appearance of the mCherry signal. 
Surprisingly, the cell-to-cell variability during the infection (which is 
indicated by presence and the intensity of mCherry labeled NS5A protein) was 
even higher than in case of the RNA transfection. Because of that, determining 
the precise time of the highest FRET response is problematic. This also makes 
catching sensor response to RNA replication difficult and forces a lot more 




Figure 34. Example of FRET/CFP ratio images of Huh7 cells expressing the 




Figure 35. Mean FRET/CFP ratio across several Huh7 cells with the sensor 




Counter-intuitively, the peak response of the sensor in case of the TCPHCV 
infection comes later, then one after the HCV replicon transfection. I expected 
the translation and replication of viral RNA to begin immediately after the 
infection, but it was not the case. 
Similarly to the HCV replicon experiment, after a certain period of time I 
can observe the massive cell death which is indicated by lower FRET readout 
compared to the non-treated cells. The difference from the HCV RNA 
transfection experiment, though, was much a higher cell death rate. This fact 
makes finding the peak FRET response time or measuring the kinetics of 
replication even more difficult.  
Application for viral infection 
The fact that I can observe FRET response during a short window of time 
after the infection, cell-to-cell variability of the infection time and high toxicity 
of the produced viral RNA steered me away from using a full Hepatitis C virus 
for the infection. Since the infected cell will be not labeled with the wild type 
virus under the microscope I decided to use a similar virus with even higher 
replication efficiency. We decided to try Dengue virus (DENV) – also a single-
stranded positive-sense RNA virus. The difference of DENV from HCV is a 
higher replication rate and a different mechanism of packaging newly produced 
RNA genome in the cell into a new particle at the ER.  
Unfortunately, the results of the infection of Huh7 cell expressing KRP2 
were very inconclusive. There were many cells having high FRET ratio, but also 
many cells rapidly dying. It was impossible to determine the peak FRET readout 
time point and the variability in FRET response from cell to cell was enormous. 
Different color version of the FRET sensor 
Following the advancements in fluorescent protein development and 
increased use of multiple sensors in one system, it becomes more and more 
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common to design a sensor in different “colors”. In a case of FRET it is usually 
inefficient because FRET pairs other than CFP/YFP (BFP/GFP or YFP/RFP) are 
less then optimal with often appearing problems of cross-excitation and/or 
bleedthrough. However, following the publication of the new red fluorescent 
protein with high quantum yield and brightness - mScarlet (Bindels et al., 2017) 
I decided to expand the color palette of my sensor into the red range.  
 
Figure 36. Schematic representation of the different color versions of the FRET 
sensor. 
In this publication the authors not only designed a new red fluorescent 
protein but also successfully tested it in the FRET set up with one green 
(mClover3) and two yellow fluorescent proteins (SYFP2 and YPet). 
Consequently, I replaced CFP and YFP in my sensor with mScarlet and one of 
those three proteins (Figure 36) to test the FRET readout in vitro and in live cells. 
Similarly to the original sensor, I expressed newly cloned version of KRP2 
in HeLa cells and measured emission fluorescent spectra of the native lysate in 
the cuvette in the presence or the absence of dsRNA. The lysate of mClover3 
version of the sensor was excited with 505 nm, and yellow versions – 
with 517 nm (Figure 37). Strictly speaking, mClover3 is not a green version, but 
rather an in-between version of green and yellow, with the excitation maximum 
shifted from 488 nm of GFP to 505 nm (which makes it more suitable for FRET 
with the red fluorescent protein compared to GFP). Fortunately, FRET was 
observed in all cases and, as expected, FRET ratio changed was observed during 
the titration with dsRNA (Figure 37a). The maximum FRET ratio change of the 
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mClover3 version was lower compared to yellow versions, and latter had lower 
maximum readout compared to the CFP/YFP original version (Figure 37b). There 
was no significant difference among SYFP2 and YPet, which is expected because 
SYFP2, YPet, Venus and other improved yellow fluorescent proteins have very 
similar spectrophotometric properties among each other. The control trypsin 
digestion disposed of the FRET in the same way as with the original version of 
the sensor. 
The YPet/mScarlet version of the sensor was picked for testing against 
dsRNA in live cells. The sensor was expressed in HeLa cell and transfected with 
dsRNA the next day. As expected, I observed a FRET ratio increase in many cells 





Figure 37. Example emission spectra of on the YPet/mScarlet version of the 
sensor before the addition (light line) and after the addition of dsRNA (darker 






Figure 38. Mean FRET/YFP ratio across several HeLa cells expressing 






As mentioned before, the sensor design chosen in this work (among many 
others) was based the N-terminal domain of PKR placed between a fluorescent 
protein FRET pair. Our hypothesis was that upon binding double-stranded RNA 
the PKR (1-175) domain will wrap around the RNA molecule and change its 
conformation to a more closed one which will lead to a FRET increase between 
the fluorescent proteins.  The hypothesis was correct as can be seen from 
fluorescent spectra of the sensor collected before and after addition of double-
stranded RNA.  
I can see that before the addition of any RNA there is some initial FRET 
between two fluorescent proteins in the sensor indicating that N- and C-termini 
are somewhat close to each other. This is expected and acceptable for the type of 
FRET sensors that use whole proteins or whole domains of the proteins as a 
sensing unit. In the case like that it is hard to influence the resting configuration 
of the protein or a protein domain. Ideal initial “no-FRET’ state can be seen in 
the sensors where fluorescent protein FRET pair is separated with multiple 
protein domains in the sensor construct, or when the sensor consist of two 
separate parts each carrying a fluorescent protein which come together after the 
analyte presence (for example, dimerization FRET). After the addition of double-
stranded RNA I clearly see a significant increase in FRET meaning that the 
fluorescent proteins come closer to each other. The FRET ratio change is quite 
high for this type of FRET sensors. The reason is that the N-terminal domain of 
PKR by itself consists of two subdomains separated by an unstructured 
region (which serves as linker between two almost symmetrical parts of the 
sensor) which resembles the structure of some of the FRET sensors artificially 




From the optimization experiments we can conclude that the addition of 
any sort of linkers between the “sensing” domain of the sensor and the fluorescent 
proteins impairs the readout. Flexibility in the sensor structure in this case is 
detrimental to the sensor response, while more rigid structure is more optimal for 
the FRET. Very interestingly, the orientation of the fluorophores in the sensor 
had a significant effect on the FRET response. By changing circularly permutated 
versions of one of the fluorescent proteins (the optimal version of YFP in the 
current sensor was “wild-type”) we managed to increase the dynamic range of 
the sensor more than two times, while the proximity between two fluorescent 
protein remain the same. 
Substituting the optimal CFP/YFP pair to YFP/RFP pair substantially 
reduced the dynamic range of KRP1 despite using a new extremely bright version 
of RFP as an acceptor – mScarlet (with the twice higher quantum yield than 
mCherry). The use of even the most novel and bright fluorescent protein still 
cannot match the CFP/YFP pair in terms of FRET efficiency. Still worth 
mentioning, though, that the continuous development in the fluorescent protein 
filed has permitted to have alternative color versions of FRET sensors with 
reasonable readout. 
Sensor interaction with double-stranded RNA 
Sensors is able to detect double-stranded RNA very efficiently.  In this 
work I confirmed numerous previous reports suggested that PKR binds 
double-stranded RNA sequence-independently (Mayo and Cole, 2017, Husain et 
al., 2015, Patel et al., 2012, Nallagatla et al., 2011, Lemaire et al., 2008). During 
the project several dsRNAs were tested with the sensor: 30 bp RNA duplex 
(previously reported to be of a minimal length required for a proper PKR activity, 
(Lemaire et al., 2008)), different polyI:C mixtures (polymer nucleic acid mixture 
of relatively short or relatively long length which is commonly used to induce an 
interferon response and mimic viral infection), 200 bp double-stranded RNA 
duplex (randomly chosen, first 200 nt of the ampicillin sequence) and polyA:U 
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mix (alternative to polyI:C in mimicking a viral infection response, activates 
different receptors in the cell). In all cases, the same FRET ratio change was 
observed. Among these different RNA versions the response depended on the 
total mass of the added substrate rather than the “moles” which indicates that 
several PKR molecules can land on top of one RNA duplex up until it is fully 
covered.  
Moreover, in current work I confirmed previous studies reporting extreme 
specificity of the PKR to dsRNA. PKR did show any significant FRET response 
(and therefore no binding) to any other nucleic acid molecule both in vitro and in 
the live cells. This is due to a perfect fit of the N-terminal domain of PKR to the 
A-helix structure of dsRNA discussed in the introduction section of this thesis. 
PKR can even differentiate dsRNA from the RNA/DNA duplex (Zheng and 
Bevilacqua, 2004), although this was not tested in this work.  
Additionally, I took advantage of the observation made by many FRET 
sensor users which claim that the unspecific proteases can cleave the FRET sensor 
much quicker than the fluorescent proteins which results in the loss of FRET but 
the fluorescence remains. During the in vitro measurements in the fluorimeter I 
routinely added trypsin to the sensor before or after the addition of RNA to see 
the loss of FRET and the recovery of the CFP fluorescence as a control for CFP 
bleedthrough and YFP cross-excitation. The trypsin digestion indeed targeted 
fluorescent proteins (or at very least the fluorophores protected by the tight β-
barrel structure) significantly slower. 
Sensor performance in live cells 
In this thesis we proved the ability to detect dsRNA with the sensor in live 
cells via the fluorescent microscopy. For the sensor imaging it is possible to use 
either widefield fluorescent microscope (high intensity, signal bleedthrough 
depends on the quality of the emission filters), confocal microscope (lower 
intensity, sharper cells for more convenient image analysis and minimal 
bleedthrough or cross-excitation) or any derivatives of the confocal microscope 
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like the “spinning-disk”. I successfully tested the sensor not only in HeLa and 
Huh7 cells (data shown) but also in HEK293T, COS7 and MIN6 cells (data not 
shown). As expected, the sensor works via direct binding to dsRNA and the 
biological environment is irrelevant to the sensor performance. Therefore, the 
sensor can be used in any cell line provided the RNA can be introduced inside the 
cell. 
The FRET ratio of the sensor is independent of the expression level of the 
sensor inside the cell. This feature is very appealing since, often, FRET of the 
sensor in the absence of the substrate can still vary from cell to cell depending on 
the expression level (for example, some kinase sensors which can partly be 
phosphorylated by other cellular kinases). 
Sensor is able to detect all types of dsRNA used in this work. The clear 
FRET ratio increase observed in some cells clearly indicates cells which were 
transfected with RNA. Individual cells might even show the maximum possible 
FRET ratio change, although these cells will rapidly die due to a very high amount 
of dsRNA present in them. The time when the FRET response can be observed 
begins after 5h after the RNA transfection (the time needed for the 
RNA/transfection reagent complex to move inside the cell), and after ~8h the 
cells start to rapidly undergo the apoptosis. Moreover, endogenous PKR seem to 
not interfere with the sensor performance even after the long dsRNAs induces 
overexpression of the kinase via the interferon response. This is unsurprising due 
to the high amount of transfected dsRNA and the overexpression of the sensor 
inside the cell.  
Additional bonus of the sensor, clearly visible in the RNA experiments, is 
the ability to detect apoptotic cells via drop of FRET. This feature is fairly 
common in FRET sensors which experience FRET increase in the presence of the 
substrate. During the apoptosis unspecific proteases cleave the sensor which 
results in the loss of FRET, detectible under the microscope. 
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Sensor for the viral infection 
While the cell line type is irrelevant for the sensor performance during the 
study, it might be important for the virus replication. In case of HCV, which was 
an RNA virus of interest in this work, the cell line of choice was Huh7. 
Among three types of viral experiments performed here (transfection of the 
subgenomic RNAHCV replicon, TCP infection or full viral infection) the RNAHCV 
replicon provided the most unambiguous and clear results.  The FRET response 
of the sensor to the viral RNA is bell-shaped. Enough quantity of the dsRNA 
intermediate (produced due to the self-replication of viral RNA) for KRP2 
detection appears to be around 20 h after the transfection. The peak FRET 
response comes around 30 h after the transfection. Longer time results in FRET 
decay to the level of untreated cells followed by the significant drop of FRET due 
to the cell death. 
There have been three potential obstacles for the application of KRP2 for 
viral infection: competition of the endogenous PKR with the sensor for RNA 
binding, not enough quantity of produced dsRNA during the replication, and 
coverage of produced viral dsRNA with other proteins which would prevent the 
sensor binding. The first two obstacles were proven invalid in the case of HCV – 
I could clearly detect the cells with high FRET after some period of time (enough 
to accumulate the necessary minimum amount of dsRNA). Interestingly enough, 
FRET of the cells seem to drop down after long period of time which is related, 
as we presume, with the transfer and accumulation of all viral RNA near ER 
wrapped in membrane-type structures (like vesicles) (El-Hage and Luo, 2003, 
Gosert et al., 2003, Ashfaq et al., 2011). Since the RNA cannot be released due 
to the lack of viral structural proteins, the cell undergoes the apoptosis which 
leads to the drop of FRET. 
The infection with the TCPs of HCV resulted in a similar sensor response 
trend: rise of FRET during the accumulation of the viral RNA inside the cell 
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followed by a FRET decay. Curiously, the kinetics in case of TCPHCV infection 
seemed to “lag” compared to the transfection of RNAHCV replicon. The mCherry 
signal coming from translation of the viral RNA and peak FRET response of the 
sensor were observed around 10 h later (with significant cell-to-cell variability 
though) compared to the subgenomic replicon case. One could expect the viral 
cell entry to be quicker (Meertens et al., 2006) than the transfection (~2h vs ~6h) 
and be a determining factor deciding the beginning of viral replication and 
translation. However, RNA accessibility after the viral cell entry is limited for 
some time. I speculate the reason for to be the decapsulisation of the HCV 
nucleocapsid which, apparently, takes a significant amount of time. The FRET 
decay after a certain period of time is, probably, of the same origin as in the case 
of the HCV subgenomic RNA replication discussed before. The last difference 
between the viral RNA transfection and the TCPHCV infection is a much higher 
toxicity of the latter to the cells (which can be concluded by monitoring cells 
appearing with a vanished FRET). 
Potential applications of the sensor 
The original motivation for the sensor design was the ability to monitor the 
replication of RNA viruses in live cells. However, during the sensor testing many 
other potential applications have emerged. 
Because of the fact that the sensor has proven to be a very sensitive and 
extremely specific to any dsRNA, it can be used to determine levels of dsRNA 
both in vitro and in vivo. For the in vitro studies, the sensor can be expressed and 
purified, added to the solution potentially containing the dsRNA followed by the 
measurement of the emission spectra to determine FRET compared to the 
negative control. The examples could be a detection of produced viral dsRNA in 
the supernatant of the cells infected with the RNA virus or determination of the 
in vitro transcription efficiency as an alternative to agarose gel electrophoresis or 
northern blots. As for in vivo applications, spike in dsRNA levels inside the cell 
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can be clearly visible with the sensor under the microscope. For instance, one 
could monitor cells transfected with the specific siRNA in gene silencing 
experiments or localization of some overexpressed miRNAs during the 
posttranscriptional regulation of protein expression. 
Another direction in which the sensor can be applied are studies of the PKR 
biology since the sensor is based on the N-terminal RNA-binding domain of the 
kinase. The most obvious use of the sensor is the study of RNA binding to PKR. 
During current thesis, FRET turned out to be a very convenient tool to determine 
the RNA-PKR binding compared to performing pull-downs/western-blots or 
Isothermal Titration Calorimetry assays (ITC) which were done in the previous 
PKR-related works. By monitoring FRET change, we confirmed previous reports 
of PKR binding to RNA be structurally-specific and sequence-independent and, 
also, sufficiency of 30 bp of dsRNA for the efficient binding of PKR. To extend 
the understanding of PKR-RNA interaction, the sensor can be used to determine 
the minimum length of dsRNA necessary for the efficient binding (hypothesized 
to be around 12 nt  (Sambasivarao Nanduri, 1998)) or to study the impact of the 
nucleotide modifications in dsRNA on the PKR binding ability. Moreover, the 
sensor can be used to study the structure of the N-terminal domain of PKR or 
change in localization of PKR in response to different stimuli. Monitoring FRET 
change in this work I could confirm the hypothesis that the structure of the N-
terminal domain of PKR bends during the dsRNA binding, “wrapping” around 
the molecule. Additionally, in a separate unrelated to dsRNA experiment, cells 
expressing the sensor were subjected to sodium arsenate treatment or UV stress. 
This, interestingly, caused the sensor to migrate from the cytoplasm to the nucleus 
(Supplementary figures S1 and S2) confirming one previously made observation 
that the PKR during the cellular stress unrelated to dsRNA eventually migrates 
to the nucleus via unknown mechanism (Hao et al., 2016).  
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Finally, the sensor can be applied to monitor the dsRNA production during 
the replication of the RNA viruses. We successfully shown that the sensor is able 
to detect the RNA of HCV for a short period of time. With the access to Biological 
safety 3 labs with the fluorescent microscope and different dsRNA- or 
ssRNA-viruses one can monitor dsRNA accumulation inside the cell with great 
sensitivity. Unfortunately, the sensor performance heavily rely on the constant 
accessibility of the RNA for binding which can be a major drawback. Despite a 
theoretically simple and straightforward mechanism of sensor performance, the 
biology of the virus cycle can significantly impact the ability to follow any 
replication. Furthermore, the toxicity of the viral infection plays a major role 
during the sensor performance. In this work, for example, I failed to clearly 
monitor Dengue virus replication despite a higher replication efficiency of 
Dengue compared to HCV because of the massive variability in FRET from cell-
to-cell. 
Challenges and failed FRET sensor designs 
I uncovered many challenges during this project which should be discussed 
for the benefit of future related studies or application of the sensor.  
The first and a major challenge in this work was the introduction of the 
dsRNA into the cells. The big size and the negative charge of RNA does not allow 
for an easy and rapid diffusion of RNA inside the cells in the live cell experiments 
unlike the small molecule stimuli in other published FRET sensors. The use of 
transfection added a variability factor to the RNA amount inside the cells and the 
spread from cell to cell. Moreover, the dsRNA turned out to be quite toxic for the 
cells and the transfection reagent only enhanced the toxicity. All that limited my 
ability to determine the precise kinetics of sensor’s FRET response to RNA. The 
use of the electroporation as an alternative method wasn’t successful. 
In order to establish relation between the amount of RNA inside the live 
cells and a FRET response I attempted to use fluorescently labeled dsRNA. 
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Unfortunately, the hydrophobic nature of the dyes prevented the RNA to be 
internalized even in the presence of a transfection reagent. The labeled RNA was 
not able to penetrate the cellular membrane and ended up stuck in the membranes 
or accumulated in numerous vesicles. Alternatively, I tried to use microinjection 
to deliver fluorescently labeled RNA or a mixture of dsRNA with a soluble 
fluorescent dye. This lead to the leakage of the expressed sensor in the medium 
and loss of fluorescence. Waiting for the new sensor molecules to be expressed 
again and the fluorescence to recover was unsuccessful due to the apoptosis 
caused by the RNA inside the cell. 
Finally, cell-to-cell variability and the toxicity of the infection, as well as 
shielding of the viral RNA after a certain period of time, prevented me to 
determine the precise kinetics of the replication of the HCV. 
Separately, I will discuss some of the other FRET sensor designs which 
didn’t work in the application to the dsRNA or viral infection. The most 
promising idea for a FRET sensor was based on exploiting the dimerization 
ability of the PKR. The PKR dimer on top of the dsRNA is expected to be 
symmetrical (rather than anti-symmetrical) and attaching a CFP/YFP pair of 
fluorescent proteins should lead to the appearance of FRET in the presence of 
RNA when the PKR monomers come close to each other. I cloned various PKR 
constructs, including full PKR with CFP or YFP on either of the N- or the C-
terminal end, RNA-binding domain of PKR with CFP or YFP attached both to 
either N- or C-terminal end, all constructs having with various linkers lengh 
between the PKR part and the fluorescent protein. Addition of any type of dsRNA 
to the sensor both in vitro and in live cells did not lead to any FRET signal 
appearing. I can only conclude that there is something about the structure of the 
PKR dimer complex with dsRNA that is still unknown. 
In the other sensor design I attached CFP and YFP to both ends of full PKR 
and check for any conformational changes (which would lead to change in FRET 
signal) upon dsRNA binding. Some researchers speculate that in the resting state 
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RNA-binding and the catalytic domains of PKR are in a closed conformation 
relative to each other. This conformation is expected to open up upon the binding 
to dsRNA and dimerization. In the sensor I didn’t observe any FRET in the 
absence of dsRNA, therefore the fluorescent proteins were not close to each other. 
This leads me to believe that the previously described hypothesis about the latent 
PKR conformation is false. The addition of dsRNA also didn’t lead to appearance 
of FRET making the sensor inapplicable. 
Rather than detecting dsRNA presence or PKR dimerization, I attempted 
to design sensors to monitor the activity of PKR. The target of PKR activated via 
autophosphorylation is eIF2α. I cloned CFP and YFP on the both ends of eIF2α 
hoping that the phosphorylation of the initiation factor will lead to a 
conformational and, hence, FRET change. I also sandwiched the truncated 
versions of eIF2α between CFP/YFP pair: eIF2α (1-120) and eIF2α (13-90), both 
of which retained the Ser51 phosphorylation site and consisted of completed 
structural motifs. The phosphorylation of this sensors in both in vitro and live cell 
experiments did not lead to any FRET change, potentially denying the hypothesis 
of the conformational change in the eIF2α during the phosphorylation. 
As a final attempt to detect the activity of PKR, I tried to construct an 
artificial sensor on the scaffold of some other popular kinase activity FRET 
sensors. This type of sensors contain the CFP and YFP pair on the termini, a 
target-peptide of phosphorylation, flexible long linker and a phosphorylated 
amino acid-binding (PAAB) domain (Figure 7C). I used a eIF2α(45-56) 
11-amino acid peptide in this design, altering different PAAB domains and 
introducing single amino acid mutations in the peptide for improved the 
phosphorylation efficiency or PAAB domain binding efficiency. The total of 20 
different combinations of the sensor were tested both in vitro and in live cells, but 
a significant FRET change wasn’t observed (especially compared to KRP1 and 
KRP2 performance). I also observed the unusually high phosphorylation level of 
the sensor even in the absence of any stimuli, which lead me to a conclusion that 
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the peptide in the sensor can be efficiently phosphorylated by the abundant 






Conclusions and outlook 
 In this work I designed a genetically encoded FRET sensor for the purpose 
of detecting the replication of RNA viruses in live cells via fluorescent 
microscopy. 
 A FRET sensor named KRP1 consists of the N-terminal domain of protein 
kinase R (PKR 1-175) and mTurquoise/cp173Venus fluorescent protein 
pair. 
 For the sensor design I exploited the ability of the N-terminal domain of 
PKR to bind dsRNA followed by a change of its conformation. 
 In vitro experiments showed that the sensor binds dsRNA very efficiently, 
structure specifically and sequence –independently. The dynamic range 
(the maximum FRET ratio change) of this version of the sensor was 42%, 
which is quite high for this type of FRET sensors. 
 I successfully optimized the sensor using the FRET sensor optimization 
library previously developed in our lab. A version named KRP2 consists 
of mECFP, Venus (WT) and PKR (1-175) with a more than twice higher 
dynamic range of 92%. 
 The sensor was proven to work for the detection of dsRNA in various types 
of live cells with the help of widefield or confocal fluorescent microscopy. 
 I created an alternative yellow/red version of the sensor with the reduced 
but still acceptable dynamic range (possible due to the development of the 
new version of mCherry – mScarlet). 
 KRP2 was able to detect viral RNA produced during the HCV replication. 
 Cell-to-cell variability and the toxicity of the infection, as well as shielding 
of the viral RNA after a certain period of time, prevented me to determine 
the precise kinetics of the replication of the HCV. 
 Due to the simplicity of the working mechanism and the efficiency of RNA 
binding, KRP2 can have a wide range of potential application, including 
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studies of the PKR biology, detection of dsRNA or potentially monitoring 
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Figure S2. FRET ratio in the cytoplasm and the nucleus of HeLa cells expressing 
KRP2 before and after the stress. 
 
